Managing impacted wisdom teeth during nasopharyngeal cancer treatment
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This study looks at the best way to handle impacted wisdom teeth (teeth that haven't fully come in) in people receiving treatment for nasopharyngeal cancer. The goal is to reduce the risk of a serious complication called osteoradionecrosis, where the jawbone doesn't heal properly after radiation. Participation may help doctors find safer ways to manage dental issues during cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with a type of nasopharyngeal cancer called non-keratinizing carcinoma (including differentiated or undifferentiated subtypes).
- You have not yet started treatment for this cancer.
- You have at least one wisdom tooth that hasn't fully come in (impacted).
- Your cancer has not spread to other parts of the body (no distant metastasis).
- You have adequate organ function (bone marrow, liver, kidneys) as determined by blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized radiation plan for the neck can prevent cancer from spreading in people with nasopharyngeal carcinoma. It's for those whose cancer hasn't spread beyond the head and neck area.
This study helps doctors predict which patients with nasopharyngeal cancer (a cancer of the upper throat) will benefit most from additional chemotherapy after radiation treatment. It uses a special blood test and imaging to create a personalized risk score for each patient.
This trial tests whether a lower dose of radiation is just as effective as the standard dose for people with early-stage nasopharyngeal cancer, and aims to reduce side effects while keeping the cancer under control.
This trial tests whether a special analysis of blood markers and imaging scans can help doctors choose the best combination of chemotherapy and radiation for nasopharyngeal cancer. The goal is to improve outcomes by tailoring treatment to each patient's specific cancer characteristics.
This trial studies whether special nutritional supplements (immunonutrients) can reduce painful mouth sores (oral mucositis) in people with nasopharyngeal cancer after chemoradiotherapy. If you qualify, you’ll be followed with visits and lab tests to see if the supplements improve comfort and recovery.
This trial tests whether a custom-fitted dental stent (like a mouthguard) can help protect your sense of taste during radiation and chemotherapy for nasopharyngeal cancer. If you qualify, you'll receive either standard care or the stent, and your taste changes will be tracked.
Hear when a new Nasopharyngeal Carcinoma (NPC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.